From: Stereotactic body radiotherapy with or without external beam radiation as treatment for organ confined high-risk prostate carcinoma: a six year study
Pretreatment predictor
RR
95% CI
P
Hormones
1.61
7.4-3.7
0.24
EBRT
0.89
0.41-1.92
0.76
PSA (<11.5 vs ā„11.5)
3.9
1.74-9.35
0.0009
T-stage (T1 vs T2)
1.67
0.71-3.67
Gleason score (ā¤7 vs ā„8)
1.81
0.79-4.41
0.16